[Manifestation of multiple sclerosis under treatment with infliximab for intermediate uveitis]

Nervenarzt. 2011 Apr;82(4):509-10. doi: 10.1007/s00115-010-3191-5.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Multiple Sclerosis / chemically induced*
  • Multiple Sclerosis / diagnosis*
  • Treatment Outcome
  • Uveitis, Intermediate / complications*
  • Uveitis, Intermediate / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab